A new trading day began on Friday, with Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) stock price down -3.58% from the previous day of trading, before settling in for the closing price of $0.74. LXRX’s price has ranged from $0.62 to $3.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 130.38%. Meanwhile, its annual earnings per share averaged 14.05%. With a float of $168.70 million, this company’s outstanding shares have now reached $361.49 million.
Let’s determine the extent of company efficiency that accounts for 285 employees. In terms of profitability, gross margin is 87.97%, operating margin of -4037.43%, and the pretax margin is -4109.41%.
Lexicon Pharmaceuticals Inc (LXRX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Lexicon Pharmaceuticals Inc is 53.33%, while institutional ownership is 29.68%. The most recent insider transaction that took place on Aug 15 ’24, was worth 480,000.
Lexicon Pharmaceuticals Inc (LXRX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.31% during the next five years compared to 6.80% growth over the previous five years of trading.
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) Trading Performance Indicators
Here are Lexicon Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 49.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.75, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Lexicon Pharmaceuticals Inc (LXRX)
Looking closely at Lexicon Pharmaceuticals Inc (NASDAQ: LXRX), its last 5-days average volume was 2.96 million, which is a drop from its year-to-date volume of 5.24 million. As of the previous 9 days, the stock’s Stochastic %D was 7.03%. Additionally, its Average True Range was 0.10.
During the past 100 days, Lexicon Pharmaceuticals Inc’s (LXRX) raw stochastic average was set at 5.99%, which indicates a significant decrease from 8.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 108.02% in the past 14 days, which was lower than the 118.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7810, while its 200-day Moving Average is $1.4683. However, in the short run, Lexicon Pharmaceuticals Inc’s stock first resistance to watch stands at $0.7363. Second resistance stands at $0.7592. The third major resistance level sits at $0.7713. If the price goes on to break the first support level at $0.7013, it is likely to go to the next support level at $0.6892. Now, if the price goes above the second support level, the third support stands at $0.6663.
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) Key Stats
With a market capitalization of 257.92 million, the company has a total of 246,237K Shares Outstanding. Currently, annual sales are 1,200 K while annual income is -177,120 K. The company’s previous quarter sales were 1,750 K while its latest quarter income was -64,810 K.
